Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Swen Hoelder, Paul A. Clarke, Paul Workman
This review outlines contemporary approaches to small molecule cancer drug discovery, emphasizing target validation, lead optimization, and biomarker-driven trials to reduce attrition and advance personalized medicine.